Hexane and Neurodegenerative Diseases: Why European Neurologists Are Concerned

Concern is growing among European neurologists who associate the widely used petrochemical solvent hexane with increasing rates of neurodegenerative diseases. They argue that the food industry can no longer overlook the potential warning signs.

What is hexane and why it matters to your plate

Hexane is a transparent, extremely volatile liquid produced from crude oil. Its principal industrial role is as a solvent. Food manufacturers use it on a vast scale to extract oil from seeds including soya, rapeseed and sunflower. Because the method increases yields while lowering costs, it has become the worldwide industry norm.

At many European processing sites, crushed seeds are soaked in hexane. The solvent pulls out the oil before being evaporated using heat. Rules stipulate that almost all residues must be removed before the oil reaches supermarket shelves or is used in processed food. However, a threshold close to zero still permits trace amounts, which critics regard as a gap in public-health policy.

Traces of industrial solvents in everyday food raise questions at a time when neurodegenerative diseases are surging across ageing populations.

Food producers maintain that existing safety limits safeguard consumers. They note that regulators based permitted levels on the toxicological evidence available when the standards were introduced. Much of that research examined immediate toxicity and visible organ damage rather than subtle neurological effects that may emerge only decades later.

The neurologist who sees too many patients too soon

Neurologist David Devos has spent much of his working life in northern France caring for people with Parkinson’s disease. At Lille university hospital, he sees a continual stream of new patients. Many develop symptoms at a younger age than expected, affecting their jobs, family lives and independence.

Devos is known for developing a technical innovation: a pump that administers dopamine directly to the brain through a catheter. Conventional tablets can become less effective as Parkinson’s disease advances. His continuous, focused infusion is intended to steady symptoms and lessen debilitating fluctuations.

Initial research indicates that intracerebral dopamine perfusion may improve motor control more effectively than standard oral treatments for certain patients. A larger clinical trial is scheduled for around 2026 to validate these findings and clarify which patients benefit most. For Devos, this work addresses the pressing needs of those already living with the condition.

However, the unrelenting arrival of new Parkinson’s cases led him to investigate possible causes further upstream. Why are so many brains degenerating in the first place? Why are risks greater in certain occupations and regions? Those questions prompted him and other experts to revisit chemicals moving quietly through workplaces and food chains.

Hexane and the brain: what current science suggests

Within the body, hexane is broken down into several metabolites, including 2,5-hexanedione, the best-known derivative of n-hexane. This substance can harm peripheral nerves, producing numbness, burning sensations and muscle weakness. Occupational medicine has recorded such cases for decades among workers exposed to high concentrations in poorly ventilated facilities.

Neurotoxicity from hexane is not a theoretical risk; it is well established in exposed workers. The unresolved question is where the lower, chronic threshold truly lies.

Scientists are now examining whether prolonged low-level exposure, including through food and indoor air, could play a part in neurodegenerative diseases affecting the central nervous system. Laboratory findings indicate that hexane metabolites can interfere with axons, the long structures through which neurons communicate. Injury to these structures can gradually weaken entire neural circuits.

Population research is limited and frequently lacks precision. Exposure commonly involves a mixture of solvents, pesticides and metals. Nevertheless, several case-control studies suggest that Parkinson’s rates may be higher among people who have spent long periods working in agriculture, food processing, printing or solvent-intensive manufacturing.

For specialists such as Devos, this accumulating evidence supports a precautionary change, particularly where safer options are already available. They emphasise that the brain ages over many decades and that minor repeated exposures could build up into a substantial risk.

How hexane slips into daily life

From seed to shelf

Most people are unaware of hexane when buying an inexpensive bottle of vegetable oil or margarine. Packaging generally lists only “vegetable oils” or the individual seeds used. Yet the industrial production route often follows this sequence:

• Seeds are delivered to a crushing facility and pressed mechanically.
• The leftover seed cake retains a significant quantity of oil.
• Hexane passes through this cake to remove further oil.
• The solvent is heated, recovered and used again, while trace residues remain in the crude oil.
• Refining, deodorising and bottling finish the process.

Food-oil regulations generally specify maximum permitted hexane residues. Inspections test random samples, although both testing frequency and the transparency of results differ between countries. Consumers seldom have access to this information.

Other discreet sources of exposure

Hexane is not confined to food: it is also used in glues, aerosols, shoe production, furniture finishing and certain cleaning products. Fumes may be inhaled at home or at work, particularly in confined areas with poor ventilation.

Individually, each source may involve comparatively limited exposure. Together, however, they could create a background level that current regulations fail to account for, especially among people with additional risk factors such as pesticides or heavy metals.

Calls to phase out hexane from the food chain

Media attention has increased in recent months in France and elsewhere, as neurologists, toxicologists and environmental organisations call for hexane to be phased out of agri-food production. In a widely referenced opinion article, Devos and his colleagues asked governments to view the solvent as a preventable contributor to brain disease rather than merely an industrial technicality.

For clinicians on the front line of Parkinson’s and other neurodegenerative disorders, cutting avoidable neurotoxic exposures has become a form of preventive medicine.

Supporters of a phase-out say mechanical pressing methods can already provide a substantial proportion of the vegetable-oil market. Although yield per tonne of seeds is somewhat lower, the finished product often has a stronger nutritional profile and is made through a shorter, more transparent process. They also cite growing consumer interest in “first cold-pressed” and “expeller-pressed” labels, which generally indicate processing without solvents.

Industry bodies respond that an immediate ban could raise prices, undermine export competitiveness and put pressure on supply chains for processed food, ranging from biscuits to plant-based meat alternatives. They want regulators to await more conclusive epidemiological evidence before requiring expensive changes.

The policy discussion brings together health, trade and climate considerations. Solvent extraction maximises oil output from every hectare of land, matching current agricultural economics. At the same time, reducing petrochemical inputs supports wider plans to decarbonise food systems and lessen dependence on fossil fuels.

What consumers can already do

As legislators debate and scientists collect further evidence, people can take steps to lower potential exposure without radically changing their diets. None of these measures guarantees complete safety, but they generally shift consumption away from highly processed products dependent on solvents.

• Choose mechanically pressed or “cold-pressed” oils where budgets permit.
• Prepare meals with whole foods more frequently instead of ultra-processed products high in inexpensive refined fats.
• Keep kitchens and work areas ventilated, particularly when using sprays or powerful adhesives.
• Reduce indoor use of solvent-based DIY products, or use protective equipment.
• Follow occupational health requirements in work involving solvents.

These practices may reduce theoretical exposure to hexane while also reflecting broader guidance for metabolic and cardiovascular health, both of which affect brain ageing.

Why neurodegenerative risk goes beyond one solvent

A sole focus on hexane may appear too narrow. Specialists stress that Parkinson’s, Alzheimer’s and related diseases seldom result from one cause alone. Genetics, air pollution, pesticides, head injuries, lifestyle and ageing all interact. Solvents, however, belong to a category of controllable factors that policy-makers can tackle comparatively quickly.

When modelling public-health scenarios, researchers often consider the effects of removing several environmental hazards simultaneously. Cutting exposure to a group of substances that affect neurons, rather than waiting for conclusive proof against every substance separately, might alter the disease trajectory over the next two or three decades.

This reasoning is based on cumulative burden. A brain exposed to low levels of several neurotoxic agents-solvents, heavy metals and pesticides-may reach a critical threshold earlier than one exposed to only a single agent. This view encourages regulators to assess group-based restrictions and monitor exposed populations over longer periods.

For now, the discussion around hexane provides a practical test: how much uncertainty are governments willing to tolerate when neurotoxicity is established but precise long-term data for the general population remain limited? The response will influence both food-industry practices and the neurological health of future ageing societies.